HCPLive Network

Perceived Weight Gain Accurate for New Contraceptive Users

 
TUESDAY, Jan. 22 (HealthDay News) -- For new contraceptive users, perceived weight gain, reported by about one-third of users, often represents actual weight gain, according to a study published in the January issue of the American Journal of Obstetrics & Gynecology.

Ashley M. Nault, from the Washington University School of Medicine in St. Louis, and colleagues analyzed self-reported weight change data from 4,133 new contraceptive method users at three, six, and 12 months after enrollment. To assess the validity of self-reported weight gain, data were examined for a subgroup of participants with objective weight measurements at baseline and 12 months.

The researchers found that weight gain was perceived by 34 percent of participants. Implant users and depot medroxyprogesterone acetate users were more likely to report perceived weight gain than copper intrauterine device users (relative risk, 1.29 and 1.37, respectively). There was a mean actual weight gain of 10.3 pounds in women who perceived weight gain. The sensitivity of perceived weight gain was 74.6 percent and the specificity was 84.4 percent.

"In conclusion, self-reported weight change is easy to obtain and in most women represents true weight gain," the authors write. "The perception of weight gain is clinically important because it may affect a woman's satisfaction with her contraceptive method or influence a woman's decision to continue the use of the method."

Two authors disclosed financial ties to the pharmaceutical industry.
 

Abstract
Full Text


Copyright © 2013 HealthDay. All rights reserved.
 
 
Further Reading
Although patients are expressing more of an interest in accessing their health information online, just a third of patients have access to patient portals, and the rest either don't have access or are not sure if they do.
As more pediatric surgical procedures being conducted as same-day procedures, parents are assuming responsibility for their children’s immediate post-operative pain management.
Between developing its own pipeline of therapies for patients with hepatitis C and acquiring another company known for its work in this field, it looks like Merck is taking steps to be a larger player in HCV market.
As the 2 Americans stricken with Ebola continue to receive treatment in Atlanta, a new potential case of the deadly virus has been reported in California.
For patients with heart failure with reduced ejection fraction, cardiac resynchronization therapy and implantable cardioverter-defibrillator therapies are associated with clinical benefit, irrespective of patient race/ethnicity, according to a study published in the Aug. 26 issue of the Journal of the American College of Cardiology..
For preadolescent children, white matter structure varies with fitness level, according to a study published online Aug. 19 in the Frontiers of Neuroscience.
High uranium exposure is associated with systemic lupus erythematosus, according to a study published online Aug. 7 in Arthritis & Rheumatology.
More Reading